Price
Target price
€2.98
€2.98
5.300%
0.15
5.300%
€30.00
19:52 / Tradegate
WKN: 520394 / Name: B.R.A.I.N. Biotechnology / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock B.R.A.I.N. Biotechnology Research and Information Network AG is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for B.R.A.I.N. Biotechnology
sharewise wants to provide you with the best news and tools for B.R.A.I.N. Biotechnology, so we directly link to the best financial data sources.
Financials
News
EQS-News: BRAIN Biotech AG takes next step to optimize group structure
EQS-News: BRAIN Biotech AG takes next step to optimize group structure
EQS-News: Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
EQS-News: Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
EQS-News: Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
EQS-News: Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
EQS-News: Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
EQS-News: Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
EQS-News: BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives
EQS-News: BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives
EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights
EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights
EQS-News: 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24
EQS-News: 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24
EQS-News: Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy
EQS-News: Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy
EQS-News: Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy
EQS-News: Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy